Sanara Medtech Inc
NASDAQ:SMTI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Sanara Medtech Inc
Interest Income Expense
Sanara Medtech Inc
Interest Income Expense Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Sanara Medtech Inc
NASDAQ:SMTI
|
Interest Income Expense
-$7.7m
|
CAGR 3-Years
-127%
|
CAGR 5-Years
-278%
|
CAGR 10-Years
-46%
|
|
|
Haemonetics Corp
NYSE:HAE
|
Interest Income Expense
-$23.9m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-11%
|
|
|
ICU Medical Inc
NASDAQ:ICUI
|
Interest Income Expense
-$79.2m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-72%
|
CAGR 10-Years
N/A
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Interest Income Expense
$16m
|
CAGR 3-Years
44%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Interest Income Expense
$2.6m
|
CAGR 3-Years
56%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
Interest Income Expense
-$11.4m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-6%
|
|
Sanara Medtech Inc
Glance View
Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. The company is headquartered in Fort Worth, Texas and currently employs 63 full-time employees. The Company’s products include surgical wound care products, which includes CellerateRX Surgical Activated Collagen (Powder and Gel), and chronic wound care products, which include HYCOL Hydrolyzed Collagen (Powder and Gel), BIAKOS Skin and Wound Cleanser and BIAKOS Skin and Wound Gel. The surgical wound care products are used in specialties including cardiothoracic, colorectal, general surgery, hand, head and neck, high-risk obstetrics and gynecology, Mohs surgery, neurosurgery, oncology, plastic/reconstructive, podiatric, urology and vascular. The chronic wound care products are used across the post-acute continuum of care, including home health, hospice, physician offices, podiatrists, retail, skilled nursing facilities, and wound care centers.
See Also
What is Sanara Medtech Inc's Interest Income Expense?
Interest Income Expense
-7.7m
USD
Based on the financial report for Dec 31, 2025, Sanara Medtech Inc's Interest Income Expense amounts to -7.7m USD.
What is Sanara Medtech Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
-46%
Over the last year, the Interest Income Expense growth was -141%. The average annual Interest Income Expense growth rates for Sanara Medtech Inc have been -127% over the past three years , -278% over the past five years , and -46% over the past ten years .
